Group 2 innate lymphoid cells (ILC2s) are a relatively newly discovered lymphocyte population that promotes features of allergic airway diseases including asthma and chronic rhinosinusitis through secretion of the type 2 cytokines IL-4, IL-5 and IL-13 among others. This evidence concerns the gene IL5 and asthma.